Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

24.6%

% of BBP's 65 holdings also in CANC

31.9%

% of CANC's 47 holdings also in BBP

Overlap by Weight
Sector Drift (BBP minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in CANC
Overlap
DAY ONE BIOPHARMACEUTICALS, INC. 1.8% 1.8% 1.8%
GILEAD SCIENCES INC 1.8% 5.4% 1.8%
INCYTE CORP 1.6% 4.2% 1.6%
EXELIXIS INC 1.6% 3.0% 1.6%
REGENERON PHARMACEUTICALS 1.5% 5.4% 1.5%

Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to CANC
MIRUM PHARMACEUTICALS, INC. 2.4%
ALNYLAM PHARMACEUTICALS INC 2.1%
TRAVERE THERAPEUTICS, INC. 2.0%
LIGAND PHARMACEUTICALS-CL B 1.9%
LEXICON PHARMACEUTICALS, INC. 1.9%
ACADIA PHARMACEUTICALS INC 1.9%
BIOCRYST PHARMACEUTICALS INC 1.8%
IONIS PHARMACEUTICALS, INC. 1.8%
TG THERAPEUTICS INC 1.8%
ADMA BIOLOGICS, INC. 1.8%
BBP Underweight Relative to CANC
ASTRAZENECA PLC -5.2%
REVOLUTION MEDICINES, INC. -4.6%
ARGENX SE ADR -4.3%
REGENERON PHARMACEUTICALS -3.9%
ILLUMINA INC -3.8%
GILEAD SCIENCES INC -3.7%
CHUGAI PHARMACEUTICAL CO LTD -3.3%
DAIICHI SANKYO CO LTD -3.1%
MERCK & CO. INC. -2.9%
BLUEPRINT MEDICINES CORP. -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY